(1R)-2,2,4-trimethyl-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol

Metabolite details

Identifier

KOTBWDXNYNTNIY-FLCXWBGESA-N

InChI Key

KOTBWDXNYNTNIY-FLCXWBGESA-N

IUPAC name

(1R)-2,2,4-trimethyl-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol

Preferred name

(1R)-2,2,4-trimethyl-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol

INN name

—

Synonym

—

ChEBI

CHEBI:181735

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• 4-Octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING

Observed in differential profiles

• Control_vs_DMXAA16h